DRD2 and breast carcinoma: Indeed, pretreatment with D2R‐specific antagonists did not prevent the apoptosis‐inducing effect of aripiprazole but rather strengthened it, clearly demonstrating that D2R signaling is not responsible for the aripiprazole‐induced apoptosis in breast cancer cells.